InvestorsHub Logo

Bourbon_on_my_cornflakes

06/08/23 5:25 PM

#418101 RE: 12x #418092

GREAT insight: it only takes ANVS 15 months to run a 600-patient PD p3 trial in the US due to overwhelming US demand and costs only $20M. Let's seize the opportunity to start a US PD p3 trial today

The final lap is like the Belmont, go USA and go big.

jav0033

06/08/23 6:03 PM

#418104 RE: 12x #418092

They probably will have TLD by Fall this year. Missling still trying to decipher ALZ data from last year and hasn’t started ph3 PDD either.

Like Ricky Bobby said: “ if you ain’t first, you’re LAST!!”

Management has and will cost Shareholders BILLIONS in profits thanks to a egocentric moron.

Hoskuld

06/08/23 9:10 PM

#418119 RE: 12x #418092

12x will you please provide a link to a completed ANVS PD P3 USA trial with 600 patients? Thanks.